Treatment of metastatic medullary thyroid cancer with vandetanib: Need to stratify patients on basis of calcitonin doubling time - Reply Journal Article


Authors: Wells, S. A. Jr; Robinson, B. G.; Gagel, R. F.; Dralle, H.; Fagin, J. A.; Santoro, M.; Baudin, E.; Elisei, R.; Jarzab, B.; Vasselli, J. R.; Read, J. S.; Langmuir, P.; Ryan, A. J.; Schlumberger, M. J.
Article Title: Treatment of metastatic medullary thyroid cancer with vandetanib: Need to stratify patients on basis of calcitonin doubling time - Reply
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 17
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-01-01
Start Page: 2166
End Page: 2167
Language: English
DOI: 10.1200/jco.2012.42.5660
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 1 August 2012" - "CODEN: JCOND" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. James A Fagin
    180 Fagin